Sunday, August 14, 2022

TOPICS

Home Tags Rubius Therapeutics

Tag: Rubius Therapeutics

Rubius Therapeutics reports $196.5M loss in 2021

PROVIDENCE – Rubius Therapeutics Inc. on Friday reported a loss of $196.5 million in 2021, or $2.23 per diluted share.  The clinical-stage biopharmaceutical company, which...

Rubius Therapeutics ramps up R&D costs, reports $49M loss in Q3

PROVIDENCE – Rubius Therapeutics Inc. reported a $49 million loss in the third quarter, or 55 cents per diluted share, a decline from a...

Rubius Therapeutics logs $50.2M loss in Q2

CAMBRIDGE, Mass. – The clinical-stage biopharmaceutical company Rubius Therapeutics Inc. reported a loss of $50.2 million in the second quarter, or 56 cents per...

Rubius Therapeutics posts $42.3M loss in Q1

CAMBRIDGE, Mass. – Rubius Therapeutics Inc. reported a $42.3 million loss in the first quarter of 2021, or 51 cents per diluted share, the...
RUBIUS THERAPEUTICS ended 2020 with a loss of $167.7 million.

Rubius Therapeutics reports $167.7M loss in 2020

CAMBRIDGE, Mass. – Rubius Therapeutics Inc. reported Tuesday a loss of $167.7 million in 2020, or $2.08 per diluted share. The clinical-stage biopharmaceutical company, which...

Rubius Therapeutics reports $40.9M loss in Q3

CAMBRIDGE, Mass. – Rubius Therapeutics Inc. reported a loss of $40.9 million, or 51 cents per diluted share, in the third quarter. The clinical-stage biopharmaceutical...
BEST-DRESSED: Rubius Therapeutics employees participate in a “Best Sweater” contest it held on behalf of the activities team in late 2019. It was accompanied by a “Giving Tree” for local families in need. / COURTESY RUBIUS THERAPEUTICS

Rubius Therapeutics

PBN Best Places to Work 2020 MIDSIZE COMPANIES 5. Rubius Therapeutics Employees in R.I.: 64 CEO Pablo J. Cagnoni Questions answered by: Human Resources Site Head Brianne Meehan What...
PROVIDENCE BUSINESS NEWS has announced that 66 companies will be recognized in its 2020 Best Places to Work program.

PBN announces 2020 Best Places to Work honorees

PROVIDENCE – Providence Business News has announced 66 honorees for its 2020 Best Places to Work program. Each of the companies recognized for this year’s...
RUBIUS THERAPEUTICS reported a loss of $48.5 million in the first quarter of 2020.

Rubius Therapeutics posts $48.5M loss in Q1; prioritizes on oncology and...

CAMBRIDGE, Mass. – Rubius Therapeutics Inc. posted a loss of $48.5 million for the first quarter of 2020, or a loss of 60 cents...
RUBIUS THERAPEUTICS spent $163.5 million in 2019. The company does not yet generate revenue.

Rubius Therapeutics reports $163.5M loss in 2019; focuses on oncology and...

PROVIDENCE – Rubius Therapeutics Inc. reported a year-end loss of $163.5 million in 2019, an increase from $89.2 million in 2018. Loss per diluted share...

Stay up to date with PBN's Morning Call & Daily Edition newsletters.

- Featured Event -

Latest News

Don’t miss a beat. Get every article related to Rhode Island’s 2022 elections

CLOSE

Register to keep reading or subscribe today to get unlimited access now.

ALREADY A SUBSCRIBER? LOG IN

Keep reading this subscriber-only article

with a subscription to PBN.

ALREADY A SUBSCRIBER? LOG IN

PBN is becoming a habit.
You've exceeded our free article limit for the month. Keep reading this article with a subscription to PBN.

Digital Exit Intent

SPRING SALE

CLOSE

50% off for one day only

Hurry, this offer ends in:

00
Months
00
Days
00
Hours
00
Minutes
00
Seconds

Sign-up to get the

PBN Daily Edition

A collection of all the published news of the last 24 hours, as well as selected features from PBN’s weekly print edition.

By submitting the form you agree to PBN's Privacy Policy and Terms of Use.

ANNUAL SALE

CLOSE

70% off for one day only

Hurry, this offer ends in:

00
Months
00
Days
00
Hours
00
Minutes
00
Seconds

Register to read all articles free - This week only!

CLOSE

One week only, get full access to all articles on PBN.com when you create a complimentary account.

One week only, get full access to all articles on PBN.com when you create a complimentary account.

 

Register today >>